Jul 1 |
Institutions own 38% of Anavex Life Sciences Corp. (NASDAQ:AVXL) shares but individual investors control 59% of the company
|
Jun 20 |
Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
|
May 22 |
Neutral On Anavex: Evaluating The Potential In Neurodegenerative Diseases
|
May 22 |
Sector Update: Health Care Stocks Slightly Higher Late Afternoon
|
May 22 |
Anavex Life Sciences announces expansion of leadership team
|
May 22 |
Anavex Life Sciences Announces Expansion of Leadership Team
|
May 21 |
Anavex Life Sciences (NASDAQ:AVXL) Is In A Good Position To Deliver On Growth Plans
|
May 15 |
Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?
|
May 14 |
Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
|
May 10 |
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2024 Earnings Call Transcript
|